Multinational, observational cohort study of patients with moderate to severe chronic plaque psoriasis. VALUE study / P19-377
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ABBVIE SPAIN SLU
- Execution start: 31/05/2021
- End of execution: 30/06/2025
- IP: ANTONIO MARTINEZ LOPEZ